west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "脂质运载蛋白-2" 2 results
  • 肺癌患者血清中脂质运载蛋白-2的表达及临床意义

    目的 检测脂质运载蛋白-2(Lipocalin-2)在肺癌患者血清中的表达情况及与临床指标的关系。 方法 2012年1月-5月采用酶联免疫吸附试验(ELISA)定量检测42例肺癌患者和27例正常人血清中Lipocalin-2蛋白的表达水平。 结果 肺癌组和正常对照组血清中Lipocalin-2蛋白含量分别为(89.63 ± 21.32)、(62.44 ± 18.25) ng/mL,差异有统计学意义(P<0.05)。Lipocalin-2在小细胞癌组表达水平最高[(117.73 ± 8.76) ng/mL],显著高于腺癌组[(80.33 ± 16.6) ng/mL]和鳞癌组[(89.22 ± 18.53 ng/mL],差异有统计学意义(P<0.05)。Ⅲ+Ⅳ期肺癌组的Lipocalin-2水平[(95.72 ± 15.33) ng/mL],显著高于Ⅰ期[(65.7 ± 8.77) ng/mL]和Ⅱ期[(72.75 ± 10.77) ng/mL],差异有统计学意义(P<0.05)。淋巴节转移组的Lipocalin-2水平[(94.28 ± 20.92) ng/mL],显著高于未转移组[(72.55 ± 12.69) ng/mL],差异有统计学意义(P<0.05)。 结论 Lipocalin-2蛋白在肺癌患者血清中表达上调,该蛋白与肺癌的发生发展有关。

    Release date:2016-09-07 02:34 Export PDF Favorites Scan
  • Correlation of plasma lipocalin-2 with inflammation and predictive value of lipocalin-2 for detecting acute kidney injury in acute pancreatitis

    ObjectiveTo explore the correlation of serum lipocalin-2 (LCN2) with inflammation and the predictive value of LCN2 for detecting acute kidney injury (AKI) in acute pancreatitis (AP).MethodsNighty-one patients with AP, who were admitted to Bazhong Municipal Hospital of Traditional Chinese Medicine between June 2016 and June 2018, were enrolled in the present study. Clinical paramaters were analyzed between patients with AKI (n=29) and patients without AKI (n=62). The correlation of serum LCN2 with inflammation was assessed with Pearson’s correlation analysis. The area under the receiver operating characteristic curve (ROC AUC) for serum LCN2 predicting AKI in AP patients was assessed.ResultsCompared with the patients without AKI, the patients with AKI showed increased serum levels of C-reactive protein [(64.8±10.5) vs. (148.3±21.6) mg/L], procalcitonin [(3.5±2.3) vs. (4.8±3.9) μg/L], urea nitrogen [(5.5±2.1) vs. (6.6±2.8) mmol/L], creatinine [(80.3±28.1) vs. (107.3±30.8) μmol/L], interleukin-6 [(10.1±3.7) vs. (16.2±4.6) pg/mL], and LCN2 [(155.0±37.6) vs. (394.8±53.1) mg/mL], as well as decreased level of calcium [(2.6±1.3) vs. (2.0±1.0) mmol/L], the differences were all statistically significant (P<0.05). The serum level of LCN2 was correlated with C-reactive protein (r=0.694, P<0.05), interleukin-6 (r=0.762, P<0.05), and procalcitonin (r=0.555, P<0.05) in patients with AP. The ROC AUC of LCN2 for predicting AKI was 0.844 (P<0.05) , with a sensitivity of 81.3% and a specificity of 81.4% when the cut-off value was 210.2 ng/mL.ConclusionsSerum LCN2 concentration is elevated in patients with AKI. In patients with AP, serum LCN2 level is positively correlated with C-reactive protein, interleukin-6, and procalcitonin. It can be regarded as a reliable indicator for predicting AKI.

    Release date:2020-12-28 09:30 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content